BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6347400)

  • 1. Physiochemical characterization of lymphocyte inhibitory factor (LyIF) isolated from avian B and T cells.
    Martin DE; Glick B
    Cell Immunol; 1983 Jul; 79(2):383-8. PubMed ID: 6347400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte inhibitory and chemotactic factors produced by bursal and thymic lymphocytes.
    Joshi P; Glick B
    Poult Sci; 1990 Feb; 69(2):249-58. PubMed ID: 1691844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of a lymphocyte inhibitory factor (LyIF) by bursal and thymic lymphocytes.
    Subba Rao DS; Glick B
    Adv Exp Med Biol; 1977; 88():87-98. PubMed ID: 303455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of partially purified B- and T-lymphocyte inhibitory factors on the mitogenic and chemotactic responses.
    Martin DE; Glick B
    Poult Sci; 1983 Sep; 62(9):1856-9. PubMed ID: 6634612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of avian macrophages in the production of avian lymphokines.
    Joshi P; Glick B
    Dev Comp Immunol; 1990; 14(3):319-25. PubMed ID: 1698666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocyte migration and the release of thrombocyte inhibitory factor (ThrIF) by T and B cells in the chicken.
    Stinson RS; Mashaly MM; Glick B
    Immunology; 1979 Apr; 36(4):769-74. PubMed ID: 108206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on leukocyte migration inhibitory factor (LIF) produced by activated T and B cells.
    Szigeti R; Rosén A
    Lymphokine Res; 1988; 7(1):11-20. PubMed ID: 3283466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lymphocyte motility by macrophages: characterization of a lymphocyte migration inhibitory factor derived from a macrophage-like cell line.
    Ye S; Cheung HT
    Cell Immunol; 1989 Aug; 122(1):231-43. PubMed ID: 2665945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certain characteristics of human lymphocyte migration inhibitory factors (LyMIF) and the effect of ampicillin on their appearance in unstimulated and PHA-stimulated cultures.
    Skopińska-Rózewska E; Madaliński W; Lukasik R
    Acta Physiol Pol; 1983; 34(3):353-67. PubMed ID: 6372368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiochemical characterization of human histamine-induced suppressor factor.
    Rocklin RE; Blidy A; Kamal M
    Cell Immunol; 1983 Mar; 76(2):243-52. PubMed ID: 6601516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine.
    Weisbart RH; Golde DW; Spolter L; Eggena P; Rinderknecht H
    Clin Immunol Immunopathol; 1979 Dec; 14(4):441-8. PubMed ID: 389500
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of lymphocyte migration inhibition (LyMIF) and stimulatory (LyMSF) factors by T and B lymphocytes from rabbit peripheral blood stimulated with concanavalin-A.
    Skopińska E; Lukasik R
    Bull Acad Pol Sci Biol; 1980; 27(9):701-7. PubMed ID: 7004593
    [No Abstract]   [Full Text] [Related]  

  • 16. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
    Rocklin RE; Blidy A; Butler J; Minowada J
    J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.